Role of tachykinins in cough

Acute and Chronic Cough

Volumn , Issue , 2005, Pages 65-80

  Advenier, Charles ^a   Lagente, Vincent ^b   Canning, Brendan J ^c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745810986     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (76)

1. Lundberg JM. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 1996; 48:113-178.
2. Lundberg JM, Saria A. Polypeptide-containing neurons in airway smooth muscle. Ann Rev Physiol 1987; 49:557-572.
3. Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ. Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Respir J 1991; 4:673-682.
4. Ellis JL, Undem BJ. Pharmacology of non-adrenergic, non-cholinergic nerves in airway smooth muscle. Pulm Pharmacol 1994; 7:205-223.
5. Baluk P, McDonald DM. Proinflammatory peptides in sensory nerves of the airways. In: Said SI, ed. Proinflammatory and Anti-Inflammatory Peptides. New York: Dekker, 1998:45-68.
6. Fischer A, McGregor GP, Saria A, Phillipin B, KummerW. Introduction of tachykinin gene and peptide expression in guinea-pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest 1996; 98:2284-2291.
7. Canning BJ. Interactions between vagal afferent nerve subtypes mediating cough. Pulm Pharmacol Ther 2002; 156:187-192.
8. Germonpré PR, Bullock GR, Lambrecht BN, Van de Velde V, Luyten WH, Joos GF, Pauwels RA. Presence of substance P and neurokinin 1 receptors in human sputum macrophages and U-937 cells. Eur Respir J 1999; 14: 776-782.
9. Lambrecht BN, Germonpré PR, Everaert EG, Carro-Muino I, De Veerman M, De Felipe C, Hunt SP, Thielemans K, Joos GF, Pauwels RA. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol 1999; 29:3815-3825.
10. Braun A, Wieber P, Pfeufer A, Gessner R, Renz H. Differential modulation of immunoglobulin isotype production by the neuropeptides substance P, NKA and NKB. J Neuroimmunol 1999; 97:43-50.
11. Joos GF, De Swert KO, Pauwels RA. Airways inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists. Eur J Pharmacol 2001; 429:239-250.
12. Advenier C, Lagente V, Boichot E. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough. Eur Respir J 1997; 10:1892-1906.
13. Spina D, Page CP, Morley J. Sensory neuropeptides and bronchial hyperresponsiveness. In: Said SI, ed. Proinflammatory and Anti-Inflammatory Peptides. New York: Dekker, 1998:45-68.
14. Regoli D, Bourdon A, Fauchère JL. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 1994; 46:551-599.
15. Myers AC, Undem BJ. Electrophysiological effects of tachykinins and capsaicin on guinea-pig bronchial parasympathetic ganglion neurones. J Physiol 1993; 470:665-679.
16. Canning BJ, Reynolds SM, Anukwu LU, Kajetar R, Myers AC. Endogenous neurokinins facilitate synaptic transmission in guinea-pig airway parasympathetic ganglia. Am J Physiol Regul Integr Comp Physiol 2002; 283:R320-R330.
17. Mazzone SB, Geraghty DP. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterisation of receptors using selective agonists and antagonists. Br J Pharmacol 2000; 129:1121-1131.
18. Mazzone SB, Canning BJ. Synergistic interactions between airway afferent nerves subtypes mediating reflex bronchospasm in guinea-pigs. Am J Physiol Regul Integr Comp Physiol 2002; 283:R86-R98.
19. Lundberg JM, Saria A. Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature 1983; 302:251-253.
20. Forsberg K, Karlsson JA, Theodorssont E, Lundberg JM, Persson CGA. Cough and bronchoconstriction mediated by capsaicin-sensitive sensory neurons in the guinea-pig. Pulm Pharmacol 1988; 1:33-39.
21. Lalloo UG, Fox AJ, Belvisi MG, Chung KF, Barnes PJ. Capsazepine inhibits cough induced by capsaicin and citric acid but not hypertonic saline in guineapig. J Appl Physiol 1995; 79:1082-1087.
22. Widdicombe JG. Neurophysiology of the cough reflex. Eur Respir J 1995; 8:1193-1202.
23. Undem BJ, Carr MJ, Kollarik M. Physiology and plasticity of putative cough fibres in the guinea-pig. Pulm Pharmacol Ther 2002; 15:193-198.
24. Laude EA, Higgins KS, Morice AH. A comparative study of the effects of citric acid, capsaicin and resiniferatoxin on the cough challenge in guinea-pig and man. Pulm Pharmacol 1993; 6:171-175.
25. Midgren B, Hansson L, Karlsson JA, Simonsson BG, Persson CGA. Capsaicin-induced cough in humans. Am Rev Resp Dis 1992; 146:347-351.
26. Widdicombe JG. Neuroregulation of cough: implications for drug therapy. Curr Opin Pharmacol 2002; 2:256-263.
27. Kohrogi H, Graf P, Sekizawa K, Borson D, Nadel J. Neutral endopeptidase inhibitors potentiate substance P and capsaicin-induced cough in awake guinea-pigs. J Clin Invest 1988; 82:2063-2068.
28. Takahama K, Fuchikama T, Isohama Y, Kai H, Miyata T. Neurokinin A but not neurokinin B and substance P induces codeine-resistant coughs in awaked guinea-pigs. Regul Pept 1993; 42:236-237.
29. Fox AJ, Bernareggi M, Lalloo UG, Chung KF, Barnes PJ, Belvisi MG. The effect of substance P on the cough reflex and airway sensory nerves in guinea-pigs. Am J Respir Crit Care Med 1996; 153:A161.
30. Moreaux B, Nemmar A, Vincke G, Halloy D, Beerens D, Advenier C, Gustin P. Role of substance P and tachykinin receptor antagonists in citric acid-induced cough in pigs. Eur J Pharmacol 2000; 408:305-312.
31. Joos GF, Pauwels RA, Van Der Straeten ME. Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax 1987; 42:779-783.
32. 2-stimulant, on substance P-induced cough in normal subjects during upper respiratory tract infection. J Exp Med 1989; 158:105-106.
33. Prabhakar NR, Runold M, Yamamoto Y, Lagercrantz H, Cherniack NS, von Euler C. Role of the vagal afferents in substance P-induced respiratory responses in anaesthetized rabbits. Acta Physiol Scand 1987; 131:63-71.
34. Masumoto S, Takeda M, Saiki C, Takahashi T, Ojima K. Effects of tachykinins on rapidly adapting pulmonary stretch receptors and total lung resistance in anesthetized articicially ventilated rabbits. J Pharmacol Exp Ther 1997; 283:1026-1031.
35. Fox AJ. Modulation of cough and airway sensory fibres. Pulm Pharmacol 1996; 9:335-342.
36. 2 enhances chemical and mechanical sensitivities of pulmonary C-fibers. Am J Respir Crit Care Med 2000; 162:528-533.
37. Lee LY, Kwong K, Lin YS, Gu Q. Hypersensitivity of bronchopulmonary Cfibers induced by airway mucosal inflammation: cellular mechanisms. Pulm Pharmacol Ther 2002; 15:199-204.
38. Lee LY, Pisarry TE. Afferent properties and reflex functions of bronchopulmonary C-fibres. Respir Physiol 2001; 125:47-65.
39. Lee LY, Gu Q, Gleich GJ. Effect of human eosinophil granule-derived cationic proteins on C-fibre afferents in the rat lung. J Physiol 2001; 91:1318-1326.
40. Myers AC, Kajekar R, Undem BJ. Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea-pig airways. Am J Physiol Lung Cell Mol Physiol 2002; 282:L775-L781.
41. Carr MJ, Hunter DD, Jacoby DB, Undem BJ. Expression of tachykinins in non-nociceptive vagal afferent neurons during respiratory tract viral infection in guinea-pigs. Am J Respir Crit Care Med 2002; 165:1071-1075.
42. Bergren DR. Sensory receptor activation by mediators of defence reflexes in guinea-pig lungs. Respir Physiol 1997; 108:195-204.
43. Joad JP, Kott KS, Bonham AC. Nitric oxide contributes to substance Pinduced increases in lung rapidly adapting receptor activity in guinea-pigs. J Physiol 1997; 503:635-643.
44. Jordan D. Central nervous pathways and control of the airways. Respir Physiol 2001; 125:67-81.
45. Mutoh T, Bonham AC, Joad JP. Substance P in the nucleus of the solitary tract augments bronchopulmonary C-fiber reflex output. Am J Physiol 2000; 279:R1215-R1223.
46. Mazzone SB, Canning BJ. Central interactions between airway afferent nerve subtypes mediating cough. Am J Respir Crit Care Med 2003; 167:A146.
47. Mazzone SB, Geraghty DP. Respiratory action of capsaicin microinjected into the nucleus of the solitary tract: involvement of vanilloid and tachykinin receptors. Br J Pharmacol 1999; 127:473-481.
48. Girard V, Naline E, Vilain P, Emonds-Alt X, Advenier C. Effect of the two tachykinins antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthetized guinea-pig. Eur Respir J 1995; 8:1110-1114.
49. Emonds-Alt X, Proietto V, Steinberg R, Oury-Donat F, Vige X, Vilain P, Naline E, Daoui S, Advenier C, Le Fur G, Maffrand JP, Soubrié P, Pascal M. SR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: biochemical and pharmacological characterization. J Pharmacol Exp Ther 2002; 303:1171-1179.
50. Yasumitsu R, Hirayama Y, Imai T, Miyayasu K, Hiroi J. Effects of specific tachykinin receptor antagonists on citric acid-induced cough and bronchoconstriction in unanesthetized guinea-pigs. Eur J Pharmacol 1996; 300:215-219.
51. Ujiie Y, Sekizawa K, Aikawa T, Sasaki H. Evidence for substance P as an endogenous substance causing cough in guinea-pigs. Am Rev Respir Dis 1993; 148:1628-1632.
52. 2 receptor antagonist. Eur J Pharmacol 1993; 250:169-171.
53. Bolser DC, De Genno FE, O’Reilly S, McLeod RL, Hay JA. Central antitussive activity of the tachykinin receptor antagonists CP 99994 and SR 48968 in the guinea pig and cat. Br J Pharmacol 1997; 121:165-170.
54. Emonds-Alt X, Advenier C, Cognon C, Croci C, Daoui S, Ducoux JP, Landi M, Naline E, Neliat G, Poncelet M, Proietto V, Van Broek D, Vilain P, Manara L, Soubrié P, Le Fur G, Maffrand JP, Brelière JC. Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist. Neuropeptides 1997; 31:449-458.
55. Lalloo UG, Fox AJ, Bernareggi M, Belvisi MG, Chung KF, Barnes PJ. Bradykinin sensitisation of airway sensory nerves: a mechanism for captoprilinduced enhancement of the cough reflex. Am J Respir Crit Care Med 1996; 153:A162.
56. 3 receptors in citric acid-induced cough and bronchial responses in guinea-pigs. Am J Respir Crit Care Med 1998; 158:42-48.
57. Emonds-Alt X, Proietto V, Steinberg R, Advenier C, Daoui S, Naline E, Gueudet C, Michaud JC, Oury-Donat F, Poncelet M, Vilain P, Le Fur G, Maffrand JP, Soubrié P, Pascal M. Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist. Can J Physiol Pharmacol 2002; 80:482-488.
58. Hay D, Giardina GA, Griswold DE, Underwood DC, Kotzer CJ, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Martin LD, Killian D, Legos JJ, Baronne FC, Luttmann MA, Grugni M, Raveglia LF, Sarau HM. Non peptide tachykinin receptor antagonists. III SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea-pigs. J Pharmacol Exp Ther 2002; 300:314-323.
59. 2 receptor antagonist inhibits antigen-induced bronchoconstriction in sensitized guineapigs. Neuropeptides 1994; 26(suppl 1):39-40.
60. Megens AA, Ashton D, Vermeire JC, Vermote PC, Hens KA, Hillen LC, Fransen JF, Mahieu M, Heylen L, Leysen JE, Jurzak MR, Janssens F. Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2-phenylmethyl-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide(S)-hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist. J Pharmacol Exp Ther 2002; 302:696-709.
61. 1receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in asthmatic subjects. Am J Respir Crit Care Med 1994; 149:A1057.
62. Ichinose M, Nakajima N, Takahashi T, Yamamuchi H, Inoue H, Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet 1992; 340:1248-1251.
63. 2receptors involvement in capsaicin-induced cough in guinea-pigs. Am J Respir Crit Care Med 1994; 149:A186.
64. 2receptors mediate tachykinin and resiniferatoxin-induced bronchospasm in guinea-pigs. Am Rev Respir Dis 1993; 148:915-921.
65. 1 tachykinin receptors. Am Rev Respir Dis 1993; 148:909-914.
66. Kudlacz EM, Shatzer SA, Knippenberg RW, Logan DE, Poirot M, Van Giersbergen PLM, Burkholder TP. In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist. J Pharmacol Exp Ther 1996; 277:840-851.
67. 2 receptor antagonist. Eur J Pharmacol 1995; 294:677-684.
68. Anthes JC, ChapmanRW, RichardC, Eckel S, Corboz M, Hey JA, Fernandez X, Greefeder S, McLeod R, Sehring S, Rizzo C, Crawley Y, Shih NY, Piwinski J, Reichard G, Ting P, Carruthers N, Cuss FM, Billah M, Kreutner W, Egan RW. SCH 206272: a potent, orally active tachykinin NK(1), NK(2) and NK(3) receptors antagonist. Eur J Pharmacol 2002; 450:191-202.
69. Xiang A, Uchida Y, Nomura A, Lijima H, Dong F, Zhang MJ, Hasegawa S. Effects of airway inflammation on cough response in the guinea-pig. J Appl Physiol 1998; 85:1841-1854.
70. Ogawa H, Fujimura M, Saito M, Matsuda T, Akao N, Kondo D. The effect of the neurokinin antagonist FK-224 on the cough response to inhaled capsaicin in a new model of guinea-pig eosinophilic bronchitis induced by intranasal polymixin B. Clin Auton Res 1994; 4:19-27.
71. Sekizawa K, Ebihara T, Sasaki H. Role of substance P in cough during bronchoconstriction in awake guinea-pigs. Am J Respir Crit Care Med 1995; 151:815-821.
72. 1 receptors. Neuropharmacology 1994; 33:167-179.
73. 1 receptors antagonists. Eur J Pharmacol 1997; 326:201-209.
74. Diemunsch P, Grélot L. Potential of substance P antagonists as antiemetics. Drugs 2000; 60:533-546.
75. Steinberg R, Alonso R, Rouquier L, Desvignes C, Michaud JC, Cudennec A, Jung M, Simiand J, Griebel G, Emonds-Alt X, Le Fur G, Soubrie P. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin 1 receptor: II. Neurochemical and behavioral characterization. J Pharmacol Exp Ther 2002; 303:1180-1188.
76. 1) receptors antagonist. Trends Pharmacol Sci 1999; 12:485-490.